Develops drugs for retinal diseases, including retinitis pigmentosa.
Dec 2025Revenue $0.00/yrExpenses $12.8M/yr
No trendCash runway ≈ 2.0 years from Jun 2026
Figures by year
When will Kiora Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $12.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $12.8M | −$12.8M |
| Dec 2024 | $16.0M | $11.5M | $4.51M |
| Dec 2023 | $0.00 | $12.6M | −$12.6M |
| Dec 2021 | $0.00 | $14.2M | −$14.2M |
| Dec 2020 | $12.1K | $6.88M | −$6.87M |
| Dec 2018 | $1.65M | $12.5M | −$10.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.